{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:21:34Z","timestamp":1794673294871,"version":"4.9.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100920"],"award-info":[{"award-number":["32100920"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012678"],"award-info":[{"award-number":["2023A1515012678"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.108452","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:50:25Z","timestamp":1789120225000},"page":"108452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GPR75: A dual-ligand receptor for 20-HETE and CCL5 with emerging roles in central and peripheral regulation of metabolic diseases"],"prefix":"10.1016","volume":"233","author":[{"given":"Yu-Ning","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7370-4688","authenticated-orcid":false,"given":"Liang-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2026.108452_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib2","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.33549\/physiolres.935109","article-title":"Obesity, cardiovascular and neurodegenerative diseases: potential common mechanisms","volume":"72","author":"Kune","year":"2023","journal-title":"Physiol. Res."},{"key":"10.1016\/j.phrs.2026.108452_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120551","article-title":"Metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factors, and cardiovascular disease","volume":"411","author":"Kyhl","year":"2025","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.phrs.2026.108452_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.26502\/aimr.0184","article-title":"Etiology, pathophysiology, and treatment strategies in the prevention and management of metabolic syndrome","volume":"7","author":"Patial","year":"2024","journal-title":"Arch. Intern. Med. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-025-02401-w","article-title":"Diabetes and its complications: molecular mechanisms, prevention and treatment","volume":"11","author":"Zhao","year":"2026","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2026.108452_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic messengers: tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib7","first-page":"3","article-title":"M. Bl\u00fcher, An overview of obesity-related complications: the epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes","volume":"27","year":"2025","journal-title":"Diabetes Obes. & Metab."},{"issue":"6","key":"10.1016\/j.phrs.2026.108452_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70132","article-title":"Metabolic dysfunction-associated steatotic liver disease (masld): mechanisms, clinical implications and therapeutic advances","volume":"8","author":"Miller","year":"2025","journal-title":"Endocrinol. Diabetes & Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib10","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/jcm15051788","article-title":"Diabetes mellitus as an integrated microbiome, immune, and metabolic disorder with clinical implications for multisystem complications and public health","volume":"15","author":"Elbehiry","year":"2026","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib11","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.31557\/APJCP.2023.24.5.1817","article-title":"G protein-coupled receptor 75 (gpr75) as a novel molecule for targeted therapy of cancer and metabolic syndrome","volume":"24","author":"Dashti","year":"2023","journal-title":"Asian Pacific Journal Cancer Prevention Apjcp"},{"issue":"9","key":"10.1016\/j.phrs.2026.108452_bib12","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.3390\/ijms26094084","article-title":"Gpr75: advances, challenges in deorphanization, and potential as a novel drug target for disease treatment","volume":"26","author":"Han","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/10799893.2025.2541777","article-title":"Orphan g-protein coupled receptor 75 (gpr75), a unique and controversial potential therapeutic target","volume":"45","author":"Stratulat","year":"2025","journal-title":"J. Recept. Signal. Transduct. Res."},{"key":"10.1016\/j.phrs.2026.108452_bib14","doi-asserted-by":"crossref","first-page":"eabf8683","DOI":"10.1126\/science.abf8683","article-title":"Sequencing of 640,000 exomes identifies gpr75 variants associated with protection from obesity","author":"Akbari","year":"2021","journal-title":"Science (New York N. Y. ) 373(6550)"},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.bjp.0706909","article-title":"Rantes stimulates ca2+ mobilization and inositol trisphosphate (ip3) formation in cells transfected with g protein-coupled receptor 75","volume":"149","author":"Ignatov","year":"2006","journal-title":"Brit J. Pharmacol."},{"issue":"19","key":"10.1016\/j.phrs.2026.108452_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182121","article-title":"Central regulation of feeding and body weight by ciliary gpr75","volume":"134","author":"Jiang","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/bbrc.1999.0753","article-title":"Cloning and characterization of a novel orphan g-protein-coupled receptor localized to human chromosome 2p16","volume":"260","author":"Tarttelin","year":"1999","journal-title":"Biochem. Bioph Res. Co."},{"key":"10.1016\/j.phrs.2026.108452_bib18","article-title":"Cryo-em complex structure of active gpr75 with a nanobody","author":"Lv","year":"2022","journal-title":"Biorxiv"},{"issue":"18","key":"10.1016\/j.phrs.2026.108452_bib19","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1111\/bph.15525","article-title":"Uncovering the signalling, structure and function of the 20-hete-gpr75 pairing: identifying the chemokine ccl5 as a negative regulator of gpr75","volume":"178","author":"Pascale","year":"2021","journal-title":"Brit J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108452_bib20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.tcb.2020.06.002","article-title":"Conformational basis of g protein-coupled receptor signaling versatility","volume":"30","author":"Wingler","year":"2020","journal-title":"Trends Cell. Biol."},{"issue":"19","key":"10.1016\/j.phrs.2026.108452_bib21","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.jmb.2016.08.002","article-title":"Regulation, signaling, and physiological functions of g-proteins","volume":"428","author":"Syrovatkina","year":"2016","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","article-title":"G protein-coupled receptors (gpcrs): advances in structures, mechanisms, and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"21","key":"10.1016\/j.phrs.2026.108452_bib23","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.3390\/ijms222111841","article-title":"Heterotrimeric g proteins in plants: canonical and atypical g\u03b1 subunits","volume":"22","author":"Maruta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108452_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.bi.56.070187.003151","article-title":"G proteins: transducers of receptor-generated signals","volume":"56","author":"Gilman","year":"1987","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.phrs.2026.108452_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.sbi.2016.11.005","article-title":"Mechanistic insights into gpcr-g protein interactions","volume":"41","author":"Mahoney","year":"2016","journal-title":"Curr. Opin. Struc Biol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00018-004-4462-3","article-title":"G-protein signaling: back to the future","volume":"62","author":"Mccudden","year":"2005","journal-title":"Cell. Mol. Life Sci. Cmls"},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1006\/bbrc.1999.0489","article-title":"Origin of guanine nucleotides in isolated heart mitochondria","volume":"257","author":"Mckee","year":"1999","journal-title":"Biochem. Bioph Res. Co."},{"issue":"6563","key":"10.1016\/j.phrs.2026.108452_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/379311a0","article-title":"The 2.0 a crystal structure of a heterotrimeric g protein","volume":"379","author":"Lambright","year":"1996","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.phrs.2026.108452_bib29","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.0702623104","article-title":"Mapping allosteric connections from the receptor to the nucleotide-binding pocket of heterotrimeric g proteins","volume":"104","author":"Oldham","year":"2007","journal-title":"P Natl. Acad. Sci. Usa"},{"issue":"11","key":"10.1016\/j.phrs.2026.108452_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0968-0004(90)90281-F","article-title":"The p-loop--a common motif in atp- and gtp-binding proteins","volume":"15","author":"Saraste","year":"1990","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.phrs.2026.108452_bib31","first-page":"74","volume":"192","author":"Rocic","year":"2018","journal-title":"20-hete Regul. Vasc. Card. Funct. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.118.10269","volume":"72","author":"Roman","year":"2018","journal-title":"20-hete Hypertens. Beyond Hypertens. (Dallas Tex. 1979)"},{"key":"10.1016\/j.phrs.2026.108452_bib33","first-page":"1","article-title":"The cyp\/20-hete\/gpr75 axis in hypertension","volume":"94","author":"Froogh","year":"2022","journal-title":"Adv. Pharmacol. (San. Diego Calif. )"},{"issue":"11","key":"10.1016\/j.phrs.2026.108452_bib34","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-hete signals through g-protein-coupled receptor gpr75 (g(q)) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/FJC.0000000000001265","article-title":"Activation of gpr75 signaling pathway contributes to the effect of a 20-hete mimetic, 5,14-hedge, to prevent hypotensive and tachycardic responses to lipopolysaccharide in a rat model of septic shock","volume":"80","author":"Tunctan","year":"2022","journal-title":"J. Cardiovasc. Pharm."},{"issue":"21","key":"10.1016\/j.phrs.2026.108452_bib36","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-21-4029","article-title":"Cyp4f2-catalyzed metabolism of arachidonic acid promotes stromal cell-mediated immunosuppression in non-small cell lung cancer","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2026.108452_bib37","article-title":"20-hete interferes with insulin signaling and contributes to obesity-driven insulin resistance","volume":"152","author":"Gilani","year":"2021","journal-title":"Prostag Oth Lipid M"},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib38","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41598-025-85992-2","article-title":"20-hete mediates ang ii-induced cardiac hypertrophy via ros and ca(2+) signaling in h9c2 cells","volume":"15","author":"Han","year":"2025","journal-title":"Sci. Rep. -Uk"},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11064-024-04260-3","article-title":"20-hydroxyeicosatetraenoic acid regulates the src\/egfr\/nf-\u03bab signaling pathway via gpr75 to activate microglia and promote tbi in the immature brain","volume":"50","author":"Ma","year":"2024","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.147","article-title":"Role of chemokine systems in cancer and inflammatory diseases","volume":"3","author":"Li","year":"2022","journal-title":"Medcomm"},{"key":"10.1016\/j.phrs.2026.108452_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/292376","article-title":"The inflammatory chemokine ccl5 and cancer progression","author":"Aldinucci","year":"2014","journal-title":"Mediat. Inflamm. 2014"},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","article-title":"The inflammatory chemokines ccl2 and ccl5 in breast cancer","volume":"267","author":"Soria","year":"2008","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.phrs.2026.108452_bib43","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/cancers12071765","article-title":"The ccl5\/ccr5 axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/jnc.14463","article-title":"The orphan g-protein-coupled receptor 75 signaling is activated by the chemokine ccl5","volume":"146","author":"Dedoni","year":"2018","journal-title":"J. Neurochem."},{"issue":"5007","key":"10.1016\/j.phrs.2026.108452_bib45","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1902986","article-title":"Diversity of g proteins in signal transduction","volume":"252","author":"Simon","year":"1991","journal-title":"Science (New York N. Y. )"},{"issue":"4","key":"10.1016\/j.phrs.2026.108452_bib46","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","article-title":"The inositol trisphosphate\/calcium signaling pathway in health and disease","volume":"96","author":"Berridge","year":"2016","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.bjp.0706910","article-title":"Tails of the unexpected - an atypical receptor for the chemokine rantes\/ccl5 expressed in brain","volume":"149","author":"Pease","year":"2006","journal-title":"Brit J. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108452_bib48","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s00125-013-3022-x","article-title":"The novel chemokine receptor, g-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis","volume":"56","author":"Liu","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108452_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107235","article-title":"Global and endothelial g-protein coupled receptor 75 (gpr75) knockout relaxes pulmonary artery and mitigates hypoxia-induced pulmonary hypertension","volume":"153","author":"Addario","year":"2023","journal-title":"Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tcb.2024.12.006","article-title":"Adopting gpr75 in treating obesity: unraveling the knowns and unknowns of this orphan gpcr","volume":"35","author":"Jiang","year":"2025","journal-title":"Trends Cell. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib51","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2024.03.016","article-title":"Loss of gpr75 protects against non-alcoholic fatty liver disease and body fat accumulation","volume":"36","author":"Leeson-Payne","year":"2024","journal-title":"Cell. Metab."},{"issue":"12","key":"10.1016\/j.phrs.2026.108452_bib52","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1507\/endocrj.EJ25-0099","article-title":"Gpr75 signaling is dispensable for reproduction but contributes to feeding and body growth in rats on normal chow and is involved in high-fat diet-induced hyperphagia, obesity, and hyperglycemia development","volume":"72","author":"Otsuka","year":"2025","journal-title":"Endocr. J."},{"issue":"6","key":"10.1016\/j.phrs.2026.108452_bib53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jnc.15818","article-title":"Mice deficient for g-protein-coupled receptor 75 display altered presynaptic structural protein expression and disrupted fear conditioning recall","volume":"165","author":"Speidell","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2026.108452_bib54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fneur.2020.00983","article-title":"20-hete enzymes and receptors in the neurovascular unit: implications in cerebrovascular disease","volume":"11","author":"Gonzalez-Fernandez","year":"2020","journal-title":"Front. Neurol."},{"issue":"32","key":"10.1016\/j.phrs.2026.108452_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg6319","article-title":"A whole-genome reference panel of 14,393 individuals for east asian populations accelerates discovery of rare functional variants","volume":"9","author":"Choi","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2026.108452_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/DMSO.S342799","article-title":"Mice lacking gpr75 are hypophagic and thin","volume":"15","author":"Powell","year":"2022","journal-title":"Diabetes Metabolic Syndrome Obesity Targets Therapy"},{"issue":"4","key":"10.1016\/j.phrs.2026.108452_bib57","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/oby.23692","article-title":"Gpr75-deficient mice are protected from high-fat?diet-induced obesity","volume":"31","author":"Hossain","year":"2023","journal-title":"Obes. (Silver Spring Md. )"},{"issue":"4","key":"10.1016\/j.phrs.2026.108452_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady7993","article-title":"Neuronal gpr75 deficiency protects against diet-induced obesity in a humanized mouse model","volume":"12","author":"Sun","year":"2026","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.phrs.2026.108452_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.117011","article-title":"Gpr75 in glutamatergic neurons regulates body weight","volume":"45","author":"Wyler","year":"2026","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2026.108452_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2026.103515","article-title":"Antagonism of gpr75 inhibits gestational diabetes mellitus-induced placental tissue injury by preventing activation of the nlrp3 inflammasome","volume":"101","author":"Tong","year":"2026","journal-title":"Tissue Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib61","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3906\/sag-1712-147","article-title":"Determining the insulin secretion potential for certain specific g-protein coupled receptors in min6 pancreatic beta cells","volume":"49","author":"Gen","year":"2019","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.phrs.2026.108452_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1497297","article-title":"The cyp4\/20-hete\/gpr75 axis in the progression metabolic dysfunction-associated steatosis liver disease (masld) to chronic liver disease","volume":"15","author":"Hardwick","year":"2025","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108452_bib63","first-page":"10","article-title":"Hepatic gpr75 exacerbates mash through gnai2-dependent signaling","author":"Yang","year":"2026","journal-title":"Hepatol. (Baltim. Md. )"},{"key":"10.1016\/j.phrs.2026.108452_bib64","first-page":"10","article-title":"Inhibition of gpr75 alleviates lipid metabolism by activating the ampk-sirt1 signaling pathway in vitro and in vivo","author":"Wang","year":"2025","journal-title":"Mol. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108452_bib65","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/HJH.0000000000003038","article-title":"Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of cyp4a12-20-hete synthase","volume":"40","author":"Agostinucci","year":"2022","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.phrs.2026.108452_bib66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4161\/epi.27644","article-title":"Dna methylome profiling identifies novel methylated genes in african american patients with colorectal neoplasia","volume":"9","author":"Ashktorab","year":"2014","journal-title":"Epigenetics-Us"},{"issue":"4","key":"10.1016\/j.phrs.2026.108452_bib67","first-page":"1997","article-title":"Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma, Am J Transl Res","volume":"11","author":"Li","year":"2019"},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib68","first-page":"707","article-title":"Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer","volume":"19","author":"Han","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phrs.2026.108452_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1030335","article-title":"Dna methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden","volume":"12","author":"Huang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108452_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111784","article-title":"20-hete\/gpr75 pairing modulates the expression and transcriptional activity of the androgen receptor in androgen-sensitive prostate cancer cells","author":"C\u00e1rdenas","year":"2023","journal-title":"Mol. Cell. Endocrinol. 559"},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib71","article-title":"Gpr75 receptor mediates 20-hete-signaling and metastatic features of androgen-insensitive prostate cancer cells","volume":"1865","author":"C\u00e1rdenas","year":"2020","journal-title":"Biochim. Et. Biophys. Acta Mol. Cell. Biol. Lipids"},{"issue":"12","key":"10.1016\/j.phrs.2026.108452_bib72","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/HYPERTENSIONAHA.124.23634","article-title":"20-hete, blood pressure, and vascular stiffness in young adults","volume":"81","author":"Barden","year":"2024","journal-title":"Hypertens. (Dallas Tex. 1979)"},{"issue":"8","key":"10.1016\/j.phrs.2026.108452_bib73","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.freeradbiomed.2004.12.024","article-title":"Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects","volume":"38","author":"Ward","year":"2005","journal-title":"Free. Radic. Biol. & Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.108452_bib74","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.CIR.0000136808.72912.D9","article-title":"Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans","volume":"110","author":"Ward","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib75","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/HYPERTENSIONAHA.107.105395","article-title":"Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease","volume":"51","author":"Minuz","year":"2008","journal-title":"Hypertens. (Dallas Tex. 1979)"},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib76","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171496","article-title":"20-hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in cyp1a1-ren-2 transgenic rats","volume":"38","author":"Sedl\u00e1kov\u00e1","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.phrs.2026.108452_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.622882","article-title":"Early renal vasodilator and hypotensive action of epoxyeicosatrienoic acid analog (eet-a) and 20-hete receptor blocker (aaa) in spontaneously hypertensive rats","volume":"12","author":"Walkowska","year":"2021","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108452_bib78","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/HJH.0000000000002462","article-title":"Combined treatment with epoxyeicosatrienoic acid analog and 20-hydroxyeicosatetraenoic acid antagonist provides substantial hypotensive effect in spontaneously hypertensive rats","volume":"38","author":"Gawrys","year":"2020","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.phrs.2026.108452_bib79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000368508","article-title":"High salt intake increases blood pressure in normal rats: putative role of 20-hete and no evidence on changes in renal vascular reactivity","volume":"40","author":"Walkowska","year":"2015","journal-title":"Kidney Blood Press. R."},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib80","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1152\/ajprenal.00458.2015","article-title":"20-hete and cyp4a2 \u03c9-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats, American Journal of Physiology","volume":"311","author":"Dalmasso","year":"2016","journal-title":"Ren. Physiol."},{"key":"10.1016\/j.phrs.2026.108452_bib81","first-page":"229","article-title":"20-hydroxyeicosatetraenoic acid (20-hete): bioactions, receptors, vascular function, cardiometabolic disease and beyond","volume":"97","author":"Pascale","year":"2023","journal-title":"Adv. Pharmacol. (San. Diego Calif. )"},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.481","article-title":"Drug development advances in human genetics-based targets","volume":"5","author":"Zhang","year":"2024","journal-title":"Medcomm"},{"key":"10.1016\/j.phrs.2026.108452_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107517","article-title":"Improved glycemic and weight control with dulaglutide addition in sglt2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The aware-2 study","volume":"210","author":"Berra","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108452_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107635","article-title":"Pharmacological regression of atherosclerotic plaque in patients with type 2 diabetes","volume":"213","author":"Bucciarelli","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00592-025-02606-z","article-title":"Glp-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromes","volume":"63","author":"Gitto","year":"2026","journal-title":"Acta Diabetol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108452_bib86","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41574-025-01170-4","article-title":"Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors","volume":"21","author":"Lee","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108452_bib87","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4330\/wjc.v16.i5.240","article-title":"Sodium glucose cotransporter-2 inhibitors and heart disease: current perspectives","volume":"16","author":"Mondal","year":"2024","journal-title":"World J. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108452_bib88","doi-asserted-by":"crossref","first-page":"525","DOI":"10.55730\/1300-0144.5997","article-title":"The effects of liraglutide on expressions of insulin secretion and beta cell survive associated gpcr genes in pancreatic beta cells","volume":"55","author":"T\u00fcrkol","year":"2025","journal-title":"Turk. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108452_bib89","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/pharmaceutics15030965","article-title":"Sglt2 inhibitor-dapagliflozin attenuates diabetes-induced renal injury by regulating inflammation through a cyp4a\/20-hete signaling mechanism","volume":"15","author":"Dia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2026.108452_bib90","article-title":"Anti-inflammatory effects of empagliflozin and gemigliptin on lps-stimulated macrophage via the ikk\/nf-\u03bab, mkk7\/jnk, and jak2\/stat1 signalling pathways","author":"Lee","year":"2021","journal-title":"J. Immunol. Res. 2021"},{"issue":"12","key":"10.1016\/j.phrs.2026.108452_bib91","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/immunohorizons.2300077","article-title":"Sodium-glucose cotransporter-2 inhibitor, empagliflozin, suppresses the inflammatory immune response to influenza infection","volume":"7","author":"Constantinesco","year":"2023","journal-title":"Immunohorizons"},{"issue":"1","key":"10.1016\/j.phrs.2026.108452_bib92","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-017-02539-4","article-title":"20-hete promotes glucose-stimulated insulin secretion in an autocrine manner through ffar1","volume":"9","author":"Tunaru","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:36:54Z","timestamp":1794670614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":92,"alternative-id":["S1043661826003671"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108452","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPR75: A dual-ligand receptor for 20-HETE and CCL5 with emerging roles in central and peripheral regulation of metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108452"}}